Fig 5.
(A) Disease-free survival and (B) overall survival by treatment arm in patients with EGFR exon 19 and 21 mutations. HR, hazard ratio.
(A) Disease-free survival and (B) overall survival by treatment arm in patients with EGFR exon 19 and 21 mutations. HR, hazard ratio.